Original article Seul Ki Lee1, Ji Eun Choi1, Chae Min Shin2, Mi-Na Kim3 1Division of Healthcare Technology Assessment Research, 2Division for New Health Technology Assessment, National Evidence-based Healthcare Collaborating Agency, Seoul, 3Department of Laboratory Medicine Asan Medical Center University of Ulsan College of Medicine, Seoul, Korea Corresponding to Chae Min Shin, E-mail: blu0924@neca.re.kr Ann Clin Microbiol 2021;24(3):97-104. https://doi.org/10.5145/ACM.2021.24.3.4Received on 20 April 2021, Revised on 5 July 2021, Accepted on 19 August 2021, Published on 20 September 2021.Copyright © Korean Society of Clinical Microbiology. Abstract Background: Fecal microbiota transplantation against gut colonization using a multidrugresistant organism is a technique used to treat infections through normalizing the gut microbiota via fecal microbiota transplantation in patients with confirmed colonization by carbapenem-resistant Enterobacteriaceae (CRE) or vancomycin-resistant enterococci (VRE) based on a fecal culture test within the past one week. In this study, we aimed to determine the safety and effectiveness of this technique. Methods:

Original article Ung-Jun Kim1, Choon-Mee Kim2, Sook-Jin Jang1, Seul-Bi Lee1, Seong-Sik Cho1, Seok-Hoon Jeong3, Young-Jin Ko1, Seong-Ho Kang1, Geon Park1, Dong-Min Kim4, Na-Ra Yoon4, Young-Joon Ahn5, Dong-hoon Lim6, Joong-Ki Kook7 1Department of Tropical Medicine and Parasitology, Seoul National University College of Medicine, Seoul2Department of Parasitology and Tropical Medicine, Gyeongsang National University College of Medicine, Jinju;3MediCheck Research Institute, Korea Association of Health Promotion, Seoul, Korea Corresponding to Sook-Jin Jang, E-mail: sjbjang@chosun.ac.kr Ann Clin Microbiol 2020;23(1):11-20. https://doi.org/10.5145/ACM.2020.23.1.11Received on 29 May 2019, Revised on 11 September 2019, Accepted on 11 September 2019, Published on 20 June 2024.Copyright © Korean Society of Clinical Microbiology. Abstract Background: Acinetobacter baumannii infection is a significant health problem worldwide due to increased drug resistance. The limited antimicrobial alternatives for the treatment of severe infections by multidrug-resistant A. baumannii (MDRAB) make the search for other therapeutic options more urgent. Linalool, the major oil compound in Coriandrum sativum, was recently